FY02/2017 Q3 Results Earnings Release Presentation
Notification of application for manufacturing and marketing approval of HP-3060 in Japan (a transdermal system for the treatment of allergic rhinitis)
Notification of acquisition state and acquisition end of company's own shares.
Notification of regarding acquisition of own shares.
FY02/2017 Q2 Results Earnings Release Presentation